Parkwood Institute

London, Ontario N6C 5J1

1 studies enrolling now · 9 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease (AD), Cognitive Dysfunction, Dementia, Early Mild Cognitive Impairment (EMCI), Frontotemporal Dementia, Late Mild Cognitive Impairment (LMCI), Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Neurodegenerative Diseases, Significant Memory Concern (SMC)

Studies at this site

• Alzheimer's Disease Neuroimaging Initiative 4 — Enrolling by invitation
• A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease — Stopped early
• Alzheimer's Disease Neuroimaging Initiative 3 — Completed
• Continuation Study for Latozinemab — Stopped early
• A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease — Completed
• Alzheimer's Disease Neuroimaging Initiative 2 — Completed
• Intranasal Oxytocin for Frontotemporal Dementia — Status unconfirmed
• Dose-response Relationship Study of S42909 on Leg Ulcer Healing — Completed
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease — Completed